Procurement Summary
Country: USA
Summary: Ncss Onboarding Nhlbi to Nei Openspecimen
Deadline: 17 Nov 2026
Posting Date: 04 Nov 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 151948879
Document Ref. No.: 75N98027Q00054
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
34522500 - Rubber dinghies
32332100 - Dictating machines
24313111 - Hydrogen sulphide
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see detailsTender Details
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.(ii) The solicitation number is 75N98027Q00054. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable).This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii).The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to Krishagni LLC, 5528 Hennessey Ct, Apt 3N, Saint Louis, MO 63139 for onboarding the National Heart, Lung, and Blood Institute (NHLBI) to the National Eye Institute¿s (NEI) existing OpenSpecimen biobanking software instance and implementing associated Electronic Medical Record (EMR) integration services. Competition is restricted to Krishagni LLC because NHLBI¿s requirement is specifically to onboard to NEI¿s active, Krishagni-licensed and operated OpenSpecimen environment rather than to procure a separate standalone biobanking system. Acquiring a different biobanking product would not satisfy the requirement to join the existing NEI shared instance and would result in substantial duplication of software licensing, implementation, validation, and support infrastructure costs, as well as unacceptable operational delays. As the software developer, proprietor, and operator of the existing NEI OpenSpecimen environmen...
Documents
Tender Notice
Documents.zip
Sign in with Google